trending Market Intelligence /marketintelligence/en/news-insights/trending/x-7Xp_tMGBVnydmvHXyJRA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Allergan completes $2.9B LifeCell acquisition

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Banking Essentials Newsletter: May Edition

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Allergan completes $2.9B LifeCell acquisition

Allergan PLC acquired LifeCell Corp. for approximately $2.9 billion in cash.

The acquisition adds LifeCell's portfolio of reconstruction and complex hernia surgery products to Allergan's existing portfolio of medical aesthetic products, breast implants and tissue expanders.

The merger will also give Allergan access to LifeCell's manufacturing and R&D operations in New Jersey.

Guggenheim Securities and Barclays served as financial advisors to Allergan, while Debevoise & Plimpton LLP were Allergan's lead legal counsel.